162 related articles for article (PubMed ID: 11231712)
21. Subcutaneous Tranexamic Acid at the End of Life in a Patient With Hereditary Hemorrhagic Telangiectasia.
Arndt G; Wai R; Stiel H
J Palliat Med; 2024 Jun; 27(6):827-829. PubMed ID: 37768837
[TBL] [Abstract][Full Text] [Related]
22. A new and rapid method for epistaxis treatment using injectable form of tranexamic acid topically: a randomized controlled trial.
Zahed R; Moharamzadeh P; Alizadeharasi S; Ghasemi A; Saeedi M
Am J Emerg Med; 2013 Sep; 31(9):1389-92. PubMed ID: 23911102
[TBL] [Abstract][Full Text] [Related]
23. In reference to hereditary hemorrhagic telangiectasia/avastin.
Bachmann-Harildstad G
Laryngoscope; 2010 Oct; 120(10):2134. PubMed ID: 20824638
[No Abstract] [Full Text] [Related]
24. Definite hereditary hemorrhagic telangiectasia in a 60-year-old black Kenyan woman: a case report.
Kiyeng JC; Siika A; Koech C; Bloomfield GS
J Med Case Rep; 2016 May; 10(1):126. PubMed ID: 27225226
[TBL] [Abstract][Full Text] [Related]
25. Intranasal topical estrogen in the management of epistaxis in hereditary hemorrhagic telangiectasia.
Minami K; Haji T
Acta Otolaryngol; 2016; 136(5):528-31. PubMed ID: 26808464
[TBL] [Abstract][Full Text] [Related]
26. The treatment of recurrent epistaxis due to hereditary haemorrhagic telangiectasia with intranasal bevacizumab.
Alderman C; Corlett J; Cullis J
Br J Haematol; 2013 Aug; 162(4):547-8. PubMed ID: 23672440
[No Abstract] [Full Text] [Related]
27. Topical tranexamic acid (TXA) for the management of a bleeding arteriovenous fistula.
Eberle ML; Schechter-Perkins EM; Altawil Z
Am J Emerg Med; 2020 Feb; 38(2):407.e5-407.e6. PubMed ID: 31685307
[TBL] [Abstract][Full Text] [Related]
28. Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: a double-blind, randomized, placebo-controlled trial.
Riss D; Burian M; Wolf A; Kranebitter V; Kaider A; Arnoldner C
Head Neck; 2015 Jun; 37(6):783-7. PubMed ID: 24595923
[TBL] [Abstract][Full Text] [Related]
29. Topical tranexamic acid for spontaneous epistaxis.
Santander MJ; Rosenbaum A; Winter M
Medwave; 2018 Dec; 18(8):e7372. PubMed ID: 30550535
[TBL] [Abstract][Full Text] [Related]
30. Medical treatment of epistaxis in hereditary hemorrhagic telangiectasia: an evidence-based review.
Halderman AA; Ryan MW; Clark C; Sindwani R; Reh DD; Poetker DM; Invernizzi R; Marple BF
Int Forum Allergy Rhinol; 2018 Jun; 8(6):713-728. PubMed ID: 29393992
[TBL] [Abstract][Full Text] [Related]
31. Topical propranolol improves epistaxis in patients with hereditary hemorrhagic telangiectasia - a preliminary report.
Mei-Zahav M; Blau H; Bruckheimer E; Zur E; Goldschmidt N
J Otolaryngol Head Neck Surg; 2017 Oct; 46(1):58. PubMed ID: 28978360
[TBL] [Abstract][Full Text] [Related]
32. Long-term experience with intranasal bevacizumab therapy.
Steineger J; Osnes T; Heimdal K; Dheyauldeen S
Laryngoscope; 2018 Oct; 128(10):2237-2244. PubMed ID: 29469958
[TBL] [Abstract][Full Text] [Related]
33. Hereditary haemorrhagic telangiectasia (HHT): negotiating between the Scylla of bleeding and Charybdis of thrombosis.
Ghosh K; Ghosh K
Thromb Haemost; 2008 Jul; 100(1):162-4. PubMed ID: 18612556
[No Abstract] [Full Text] [Related]
34. Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose.
Dheyauldeen S; Østertun Geirdal A; Osnes T; Vartdal LS; Dollner R
Laryngoscope; 2012 Jun; 122(6):1210-4. PubMed ID: 22565282
[TBL] [Abstract][Full Text] [Related]
35. Role of topical tranexamic acid in the management of idiopathic anterior epistaxis in adult patients in the emergency department.
Logan JK; Pantle H
Am J Health Syst Pharm; 2016 Nov; 73(21):1755-1759. PubMed ID: 27769971
[TBL] [Abstract][Full Text] [Related]
36. Management of epistaxis in hereditary hemorrhagic telangiectasia. Review of 80 cases.
McCaffrey TV; Kern EB; Lake CF
Arch Otolaryngol; 1977 Nov; 103(11):627-30. PubMed ID: 921594
[TBL] [Abstract][Full Text] [Related]
37. BET 1: Tranexamic acid in epistaxis: who bloody nose?
Penrose N; May G
Emerg Med J; 2016 Nov; 33(11):823-825. PubMed ID: 28319931
[TBL] [Abstract][Full Text] [Related]
38. Avastin and diode laser: a combined modality in managing epistaxis in hereditary hemorrhagic telangiectasia.
Marglani OA; Bawazeer NA; Abu Suliman OA
Am J Otolaryngol; 2013; 34(5):603-5. PubMed ID: 23541684
[TBL] [Abstract][Full Text] [Related]
39. Topical timolol for the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
Olitsky SE
Am J Otolaryngol; 2012; 33(3):375-6. PubMed ID: 22079094
[No Abstract] [Full Text] [Related]
40. Topical tranexamic acid for the treatment of acute epistaxis in the emergency department.
Birmingham AR; Mah ND; Ran R; Hansen M
Am J Emerg Med; 2018 Jul; 36(7):1242-1245. PubMed ID: 29602670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
